Commerce of biotech products in Brazil: constitutional reasoning based on human dignity and on the fundamental right to health

Authors

  • Victor V. Carneiro de Albuquerque UniCEUB

DOI:

https://doi.org/10.11606/issn.2316-9044.v16i3p82-101

Keywords:

Biotechnology, Human Dignity, Human Rights, Right to Health.

Abstract

The recent trend of pharmaceutical industry is to develop products based on human tissues, especially by using cellular and genetic manipulation. Current Brazilian regulation is however still largely concerned with traditional synthetic drugs. This article examines one particular constitutional rule on the commercialization of human substances to assure the protection of human dignity and on the promotion of the fundamental right to health recognized by the Brazilian Constitution.

Downloads

Download data is not yet available.

Downloads

Published

2015-12-30

Issue

Vol. 16 No. 3 (2015)

Section

Argument

License

The Revista de Direito Sanitário/ Journal of Health Law adopts the conditions of the Creative Commons Attribution 4.0 Internacional. This license allows to share - "copy and redistribute the material in any medium or format for any purpose, even commercially" and adapt - "remix, transform, and build upon the material for any purpose, even commercially." Details at: https://creativecommons.org/licenses/by/4.0/deed.en

How to Cite

Albuquerque, V. V. C. de. (2015). Commerce of biotech products in Brazil: constitutional reasoning based on human dignity and on the fundamental right to health. Journal of Health Law, 16(3), 82-101. https://doi.org/10.11606/issn.2316-9044.v16i3p82-101